| Autor: |
M. Berg, A. Opardija, M. Assi, Zelalem Temesgen, K. Burke, W. El Atrouni, K. M. Koshy |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Drugs of the Future. 46:711 |
| ISSN: |
0377-8282 |
| Popis: |
A large number of candidate drugs are undergoing evaluation for their potential to modulate the pathologic host immune response to SARS-CoV-2 infection. Clinical trial efficacy and safety data are slowly emerging for several of these agents. We provide a summary of candidate immunomodulatory agents, which are registered in ClinicalTrials.gov, and for which clinical data are available. We provide the rationale for their consideration for the treatment of COVID-19, as well as report on data available from the various clinical investigations of their efficacy and safety. © 2021 Prous Science. All rights reserved. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
